References
- Zhang LC , ZhaoHL , LiuJ , HeL , YuRL , KangCM. Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening. Future Med. Chem.14(6), 393–405 (2022).
- Fiorentino F , MautoneN , MennaM , D'AcunzoF , MaiA , RotiliA. Sirtuin modulators: past, present, and future perspectives. Future Med. Chem.14(12), 915–939 (2022).
- MacDonald S . Medicinal chemistry in big pharma has a gender diversity problem. Future Med. Chem.14(19), 1345–1347 (2022).
- Felicetti T , MassariS. Protein–protein interactions by influenza polymerase subunits as drug targets. Future Med. Chem.14(2), 53–56 (2022).
- Fischer F , AlvesAvelar LA , MurrayL , KurzT. Designing HDAC-PROTACs: lessons learned so far. Future Med. Chem.14(3), 143–166 (2022).
- Future Medicine . Future Science special issue proposal form. www.tandfonline.com/special-issues (Accessed 27January2023).
- Twitter . Future Medicinal Chemistry twitter page. https://twitter.com/fsgfmc (Accessed 27January2023).
- LinkedIn . Future Medicinal Chemistry LinkedIn group. www.linkedin.com/groups/2822505/ (Accessed 27January2023).
- Future Science . Future Medicinal Chemistry. www.tandfonline.com/journal/fmc (Accessed 27January2023).